Stockreport

Late-breaking Abstract at ASH Supports Evidence on Transformative First-ever Treatment in Primary HLH

SWEDISH ORPHAN ADR  (SWTUY) 
NASDAQ:AMEX Investor Relations: sobi.com/en/investors-and-media
PDF STOCKHOLM, Nov. 22, 2018 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi™) and Novimmune SA are pleased to announce that the abstract "Safety and efficacy of em [Read more]